Ask AI

Search

Loading...

Table of contents

Non-esophageal eosinophilic gastrointestinal disorders

What's new

Added 2023 ESPGHAN/NASPGHAN guidelines for the diagnosis and management of non-esophageal eosinophilic gastrointestinal disorders.

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of non-esophageal eosinophilic gastrointestinal disorders are prepared by our editorial team based on guidelines from the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN/NASPGHAN 2024). ...
Show more

Screening and diagnosis

Terminology: as per ESPGHAN/NASPGHAN 2024 guidelines, use the term non-esophageal eosinophilic gastrointestinal disorders to describe chronic inflammatory disorders of the gastrointestinal tract beyond the esophagus characterized clinically by the presence of gastrointestinal symptoms and histologically by eosinophilic predominant inflammation of the gastrointestinal tract, in the absence of an identifiable secondary cause.
A
Show 3 more
Create free account

More topics in this section

  • Diagnostic criteria

  • Differential diagnosis

Diagnostic investigations

General principles
As per ESPGHAN/NASPGHAN 2024 guidelines:
Consider obtaining an initial evaluation in patients with symptoms suggestive of non-esophageal eosinophilic gastrointestinal disorders individualized based on history, clinical examination, and associated laboratory testing.
C
Consider using an algorithm to guide the diagnostic approach of pediatric and adolescent patients with symptoms suggestive of non-esophageal eosinophilic gastrointestinal disorders.
C

More topics in this section

  • Blood tests

  • Fecal calprotectin

  • Food allergy tests

  • Diagnostic imaging

Diagnostic procedures

Endoscopy and biopsy: as per ESPGHAN/NASPGHAN 2024 guidelines, guide the choice of endoscopic examinations of the gastrointestinal tract by symptoms, laboratory, and radiographic findings.
A
Show 4 more

More topics in this section

  • Ascitic fluid analysis

Medical management

General principles: as per ESPGHAN/NASPGHAN 2024 guidelines, consider individualizing initial treatment in pediatric patients with non-esophageal eosinophilic gastrointestinal disorders based on symptoms, impact on growth and development, and other comorbid features with an attempt to involve patients and parents/caregivers in shared decision-making.
C
Show 2 more

More topics in this section

  • Corticosteroids

  • Acid suppressive therapy

  • Combination therapy

  • Agents with no evidence for benefit

Nonpharmacologic interventions

Dietary modifications
As per ESPGHAN/NASPGHAN 2024 guidelines:
Consider offering empiric elimination diets in selected patients with non-esophageal eosinophilic gastrointestinal disorders.
C
Avoid obtaining food allergy tests to guide dietary restriction therapy in patients with non-esophageal eosinophilic gastrointestinal disorders.
D

Therapeutic procedures

Endoscopic dilation: as per ESPGHAN/NASPGHAN 2024 guidelines, consider performing endoscopic dilation in addition to medical/dietary treatment in selected cases with significant objective signs of obstruction.
C

Surgical interventions

Indications for surgery: as per ESPGHAN/NASPGHAN 2024 guidelines, consider performing surgery in patients with non-esophageal eosinophilic gastrointestinal disorders with refractory ulcers, intestinal perforation, or bowel obstruction unable to be controlled otherwise.
C

Follow-up and surveillance

Laboratory follow-up
As per ESPGHAN/NASPGHAN 2024 guidelines:
Consider using peripheral eosinophilia when consistently associated with mucosal eosinophilia in individual patients as an adjunct to monitor non-esophageal eosinophilic gastrointestinal disorder disease activity.
C
Consider obtaining blood tests to monitor treatment responses in selected cases.
C

More topics in this section

  • Endoscopic follow-up